Table of Contents 1 Market Overview 1.1 Bile Duct Cancer Introduction 1.2 Market Analysis by Type 1.2.1 5-fluorouracil 1.2.2 Gemcitabine 1.2.3 Cisplatin 1.2.4 Other 1.3 Market Analysis by Applications 1.3.1 Hospitals & Clinics 1.3.2 Other 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2013-2023) 1.4.1.2 Canada Market States and Outlook (2013-2023) 1.4.1.3 Mexico Market States and Outlook (2013-2023) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2013-2023) 1.4.2.2 France Market States and Outlook (2013-2023) 1.4.2.3 UK Market States and Outlook (2013-2023) 1.4.2.4 Russia Market States and Outlook (2013-2023) 1.4.2.5 Italy Market States and Outlook (2013-2023) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2013-2023) 1.4.3.2 Japan Market States and Outlook (2013-2023) 1.4.3.3 Korea Market States and Outlook (2013-2023) 1.4.3.4 India Market States and Outlook (2013-2023) 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2013-2023) 1.4.4.2 Egypt Market States and Outlook (2013-2023) 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023) 1.4.4.4 South Africa Market States and Outlook (2013-2023) 1.4.4.5 Nigeria Market States and Outlook (2013-2023) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Pfizer 2.1.1 Business Overview 2.1.2 Bile Duct Cancer Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Pfizer Bile Duct Cancer Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2 F. Hoffmann-La Roche 2.2.1 Business Overview 2.2.2 Bile Duct Cancer Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 F. Hoffmann-La Roche Bile Duct Cancer Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3 Bristol-Myers Squibb 2.3.1 Business Overview 2.3.2 Bile Duct Cancer Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Bristol-Myers Squibb Bile Duct Cancer Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4 Teva Pharmaceutical 2.4.1 Business Overview 2.4.2 Bile Duct Cancer Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Teva Pharmaceutical Bile Duct Cancer Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5 Eli Lilly and Company 2.5.1 Business Overview 2.5.2 Bile Duct Cancer Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Eli Lilly and Company Bile Duct Cancer Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6 Sanofi 2.6.1 Business Overview 2.6.2 Bile Duct Cancer Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Sanofi Bile Duct Cancer Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7 Fresenius Kabi 2.7.1 Business Overview 2.7.2 Bile Duct Cancer Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Fresenius Kabi Bile Duct Cancer Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.8 Mylan 2.8.1 Business Overview 2.8.2 Bile Duct Cancer Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Mylan Bile Duct Cancer Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 3 Global Bile Duct Cancer Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017) 3.1 Global Bile Duct Cancer Sales and Market Share by Manufacturer (2016-2017) 3.2 Global Bile Duct Cancer Revenue and Market Share by Manufacturer (2016-2017) 3.3 Market Concentration Rate 3.3.1 Top 3 Bile Duct Cancer Manufacturer Market Share in 2017 3.3.2 Top 6 Bile Duct Cancer Manufacturer Market Share in 2017 3.4 Market Competition Trend 4 Global Bile Duct Cancer Market Analysis by Regions 4.1 Global Bile Duct Cancer Sales, Revenue and Market Share by Regions 4.1.1 Global Bile Duct Cancer Sales and Market Share by Regions (2013-2018) 4.1.2 Global Bile Duct Cancer Revenue and Market Share by Regions (2013-2018) 4.2 North America Bile Duct Cancer Sales and Growth Rate (2013-2018) 4.3 Europe Bile Duct Cancer Sales and Growth Rate (2013-2018) 4.4 Asia-Pacific Bile Duct Cancer Sales and Growth Rate (2013-2018) 4.5 South America Bile Duct Cancer Sales and Growth Rate (2013-2018) 4.6 Middle East and Africa Bile Duct Cancer Sales and Growth Rate (2013-2018) 5 North America Bile Duct Cancer by Countries 5.1 North America Bile Duct Cancer Sales, Revenue and Market Share by Countries 5.1.1 North America Bile Duct Cancer Sales and Market Share by Countries (2013-2018) 5.1.2 North America Bile Duct Cancer Revenue and Market Share by Countries (2013-2018) 5.2 United States Bile Duct Cancer Sales and Growth Rate (2013-2018) 5.3 Canada Bile Duct Cancer Sales and Growth Rate (2013-2018) 5.4 Mexico Bile Duct Cancer Sales and Growth Rate (2013-2018) 6 Europe Bile Duct Cancer by Countries 6.1 Europe Bile Duct Cancer Sales, Revenue and Market Share by Countries 6.1.1 Europe Bile Duct Cancer Sales and Market Share by Countries (2013-2018) 6.1.2 Europe Bile Duct Cancer Revenue and Market Share by Countries (2013-2018) 6.2 Germany Bile Duct Cancer Sales and Growth Rate (2013-2018) 6.3 UK Bile Duct Cancer Sales and Growth Rate (2013-2018) 6.4 France Bile Duct Cancer Sales and Growth Rate (2013-2018) 6.5 Russia Bile Duct Cancer Sales and Growth Rate (2013-2018) 6.6 Italy Bile Duct Cancer Sales and Growth Rate (2013-2018) 7 Asia-Pacific Bile Duct Cancer by Countries 7.1 Asia-Pacific Bile Duct Cancer Sales, Revenue and Market Share by Countries 7.1.1 Asia-Pacific Bile Duct Cancer Sales and Market Share by Countries (2013-2018) 7.1.2 Asia-Pacific Bile Duct Cancer Revenue and Market Share by Countries (2013-2018) 7.2 China Bile Duct Cancer Sales and Growth Rate (2013-2018) 7.3 Japan Bile Duct Cancer Sales and Growth Rate (2013-2018) 7.4 Korea Bile Duct Cancer Sales and Growth Rate (2013-2018) 7.5 India Bile Duct Cancer Sales and Growth Rate (2013-2018) 7.6 Southeast Asia Bile Duct Cancer Sales and Growth Rate (2013-2018) 8 South America Bile Duct Cancer by Countries 8.1 South America Bile Duct Cancer Sales, Revenue and Market Share by Countries 8.1.1 South America Bile Duct Cancer Sales and Market Share by Countries (2013-2018) 8.1.2 South America Bile Duct Cancer Revenue and Market Share by Countries (2013-2018) 8.2 Brazil Bile Duct Cancer Sales and Growth Rate (2013-2018) 8.3 Argentina Bile Duct Cancer Sales and Growth Rate (2013-2018) 8.4 Colombia Bile Duct Cancer Sales and Growth Rate (2013-2018) 9 Middle East and Africa Bile Duct Cancer by Countries 9.1 Middle East and Africa Bile Duct Cancer Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa Bile Duct Cancer Sales and Market Share by Countries (2013-2018) 9.1.2 Middle East and Africa Bile Duct Cancer Revenue and Market Share by Countries (2013-2018) 9.2 Saudi Arabia Bile Duct Cancer Sales and Growth Rate (2013-2018) 9.3 UAE Bile Duct Cancer Sales and Growth Rate (2013-2018) 9.4 Egypt Bile Duct Cancer Sales and Growth Rate (2013-2018) 9.5 Nigeria Bile Duct Cancer Sales and Growth Rate (2013-2018) 9.6 South Africa Bile Duct Cancer Sales and Growth Rate (2013-2018) 10 Global Bile Duct Cancer Market Segment by Type 10.1 Global Bile Duct Cancer Sales, Revenue and Market Share by Type (2013-2018) 10.1.1 Global Bile Duct Cancer Sales and Market Share by Type (2013-2018) 10.1.2 Global Bile Duct Cancer Revenue and Market Share by Type (2013-2018) 10.2 5-fluorouracil Sales Growth and Price 10.2.1 Global 5-fluorouracil Sales Growth (2013-2018) 10.2.2 Global 5-fluorouracil Price (2013-2018) 10.3 Gemcitabine Sales Growth and Price 10.3.1 Global Gemcitabine Sales Growth (2013-2018) 10.3.2 Global Gemcitabine Price (2013-2018) 10.4 Cisplatin Sales Growth and Price 10.4.1 Global Cisplatin Sales Growth (2013-2018) 10.4.2 Global Cisplatin Price (2013-2018) 10.5 Other Sales Growth and Price 10.5.1 Global Other Sales Growth (2013-2018) 10.5.2 Global Other Price (2013-2018) 11 Global Bile Duct Cancer Market Segment by Application 11.1 Global Bile Duct Cancer Sales Market Share by Application (2013-2018) 11.2 Hospitals & Clinics Sales Growth (2013-2018) 11.3 Other Sales Growth (2013-2018) 12 Bile Duct Cancer Market Forecast (2018-2023) 12.1 Global Bile Duct Cancer Sales, Revenue and Growth Rate (2018-2023) 12.2 Bile Duct Cancer Market Forecast by Regions (2018-2023) 12.2.1 North America Bile Duct Cancer Market Forecast (2018-2023) 12.2.2 Europe Bile Duct Cancer Market Forecast (2018-2023) 12.2.3 Asia-Pacific Bile Duct Cancer Market Forecast (2018-2023) 12.2.4 South America Bile Duct Cancer Market Forecast (2018-2023) 12.2.5 Middle East and Africa Bile Duct Cancer Market Forecast (2018-2023) 12.3 Bile Duct Cancer Market Forecast by Type (2018-2023) 12.3.1 Global Bile Duct Cancer Sales Forecast by Type (2018-2023) 12.3.2 Global Bile Duct Cancer Market Share Forecast by Type (2018-2023) 12.4 Bile Duct Cancer Market Forecast by Application (2018-2023) 12.4.1 Global Bile Duct Cancer Sales Forecast by Application (2018-2023) 12.4.2 Global Bile Duct Cancer Market Share Forecast by Application (2018-2023) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source

List of Tables and Figures Figure Bile Duct Cancer Picture Table Product Specifications of Bile Duct Cancer Figure Global Sales Market Share of Bile Duct Cancer by Types in 2017 Table Bile Duct Cancer Types for Major Manufacturers Figure 5-fluorouracil Picture Figure Gemcitabine Picture Figure Cisplatin Picture Figure Other Picture Figure Bile Duct Cancer Sales Market Share by Applications in 2017 Figure Hospitals & Clinics Picture Figure Other Picture Figure United States Bile Duct Cancer Revenue (Value) and Growth Rate (2013-2023) Figure Canada Bile Duct Cancer Revenue (Value) and Growth Rate (2013-2023) Figure Mexico Bile Duct Cancer Revenue (Value) and Growth Rate (2013-2023) Figure Germany Bile Duct Cancer Revenue (Value) and Growth Rate (2013-2023) Figure France Bile Duct Cancer Revenue (Value) and Growth Rate (2013-2023) Figure UK Bile Duct Cancer Revenue (Value) and Growth Rate (2013-2023) Figure Russia Bile Duct Cancer Revenue (Value) and Growth Rate (2013-2023) Figure Italy Bile Duct Cancer Revenue (Value) and Growth Rate (2013-2023) Figure China Bile Duct Cancer Revenue (Value) and Growth Rate (2013-2023) Figure Japan Bile Duct Cancer Revenue (Value) and Growth Rate (2013-2023) Figure Korea Bile Duct Cancer Revenue (Value) and Growth Rate (2013-2023) Figure India Bile Duct Cancer Revenue (Value) and Growth Rate (2013-2023) Figure Southeast Asia Bile Duct Cancer Revenue (Value) and Growth Rate (2013-2023) Figure Brazil Bile Duct Cancer Revenue (Value) and Growth Rate (2013-2023) Figure Egypt Bile Duct Cancer Revenue (Value) and Growth Rate (2013-2023) Figure Saudi Arabia Bile Duct Cancer Revenue (Value) and Growth Rate (2013-2023) Figure South Africa Bile Duct Cancer Revenue (Value) and Growth Rate (2013-2023) Figure Nigeria Bile Duct Cancer Revenue (Value) and Growth Rate (2013-2023) Table Pfizer Basic Information, Manufacturing Base and Competitors Table Pfizer Bile Duct Cancer Type and Applications Table Pfizer Bile Duct Cancer Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors Table F. Hoffmann-La Roche Bile Duct Cancer Type and Applications Table F. Hoffmann-La Roche Bile Duct Cancer Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors Table Bristol-Myers Squibb Bile Duct Cancer Type and Applications Table Bristol-Myers Squibb Bile Duct Cancer Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors Table Teva Pharmaceutical Bile Duct Cancer Type and Applications Table Teva Pharmaceutical Bile Duct Cancer Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Eli Lilly and Company Basic Information, Manufacturing Base and Competitors Table Eli Lilly and Company Bile Duct Cancer Type and Applications Table Eli Lilly and Company Bile Duct Cancer Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Sanofi Basic Information, Manufacturing Base and Competitors Table Sanofi Bile Duct Cancer Type and Applications Table Sanofi Bile Duct Cancer Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Fresenius Kabi Basic Information, Manufacturing Base and Competitors Table Fresenius Kabi Bile Duct Cancer Type and Applications Table Fresenius Kabi Bile Duct Cancer Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Mylan Basic Information, Manufacturing Base and Competitors Table Mylan Bile Duct Cancer Type and Applications Table Mylan Bile Duct Cancer Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Global Bile Duct Cancer Sales by Manufacturer (2016-2017) Figure Global Bile Duct Cancer Sales Market Share by Manufacturer in 2016 Figure Global Bile Duct Cancer Sales Market Share by Manufacturer in 2017 Table Global Bile Duct Cancer Revenue by Manufacturer (2016-2017) Figure Global Bile Duct Cancer Revenue Market Share by Manufacturer in 2016 Figure Global Bile Duct Cancer Revenue Market Share by Manufacturer in 2017 Figure Top 3 Bile Duct Cancer Manufacturer (Revenue) Market Share in 2017 Figure Top 6 Bile Duct Cancer Manufacturer (Revenue) Market Share in 2017 Figure Global Bile Duct Cancer Sales and Growth Rate (2013-2018) Figure Global Bile Duct Cancer Revenue and Growth Rate (2013-2018) Table Global Bile Duct Cancer Sales by Regions (2013-2018) Table Global Bile Duct Cancer Sales Market Share by Regions (2013-2018) Table Global Bile Duct Cancer Revenue by Regions (2013-2018) Figure Global Bile Duct Cancer Revenue Market Share by Regions in 2013 Figure Global Bile Duct Cancer Revenue Market Share by Regions in 2017 Figure North America Bile Duct Cancer Sales and Growth Rate (2013-2018) Figure Europe Bile Duct Cancer Sales and Growth Rate (2013-2018) Figure Asia-Pacific Bile Duct Cancer Sales and Growth Rate (2013-2018) Figure South America Bile Duct Cancer Sales and Growth Rate (2013-2018) Figure Middle East and Africa Bile Duct Cancer Sales and Growth Rate (2013-2018) Figure North America Bile Duct Cancer Revenue and Growth Rate (2013-2018) Table North America Bile Duct Cancer Sales by Countries (2013-2018) Table North America Bile Duct Cancer Sales Market Share by Countries (2013-2018) Figure North America Bile Duct Cancer Sales Market Share by Countries in 2013 Figure North America Bile Duct Cancer Sales Market Share by Countries in 2017 Table North America Bile Duct Cancer Revenue by Countries (2013-2018) Table North America Bile Duct Cancer Revenue Market Share by Countries (2013-2018) Figure North America Bile Duct Cancer Revenue Market Share by Countries in 2013 Figure North America Bile Duct Cancer Revenue Market Share by Countries in 2017 Figure United States Bile Duct Cancer Sales and Growth Rate (2013-2018) Figure Canada Bile Duct Cancer Sales and Growth Rate (2013-2018) Figure Mexico Bile Duct Cancer Sales and Growth Rate (2013-2018) Figure Europe Bile Duct Cancer Revenue and Growth Rate (2013-2018) Table Europe Bile Duct Cancer Sales by Countries (2013-2018) Table Europe Bile Duct Cancer Sales Market Share by Countries (2013-2018) Table Europe Bile Duct Cancer Revenue by Countries (2013-2018) Figure Europe Bile Duct Cancer Revenue Market Share by Countries in 2016 Figure Europe Bile Duct Cancer Revenue Market Share by Countries in 2017 Figure Germany Bile Duct Cancer Sales and Growth Rate (2013-2018) Figure UK Bile Duct Cancer Sales and Growth Rate (2013-2018) Figure France Bile Duct Cancer Sales and Growth Rate (2013-2018) Figure Russia Bile Duct Cancer Sales and Growth Rate (2013-2018) Figure Italy Bile Duct Cancer Sales and Growth Rate (2013-2018) Figure Asia-Pacific Bile Duct Cancer Revenue and Growth Rate (2013-2018) Table Asia-Pacific Bile Duct Cancer Sales by Countries (2013-2018) Table Asia-Pacific Bile Duct Cancer Sales Market Share by Countries (2013-2018) Figure Asia-Pacific Bile Duct Cancer Sales Market Share by Countries 2017 Table Asia-Pacific Bile Duct Cancer Revenue by Countries (2013-2018) Figure Asia-Pacific Bile Duct Cancer Revenue Market Share by Countries 2017 Figure China Bile Duct Cancer Sales and Growth Rate (2013-2018) Figure Japan Bile Duct Cancer Sales and Growth Rate (2013-2018) Figure Korea Bile Duct Cancer Sales and Growth Rate (2013-2018) Figure India Bile Duct Cancer Sales and Growth Rate (2013-2018) Figure Southeast Asia Bile Duct Cancer Sales and Growth Rate (2013-2018) Figure South America Bile Duct Cancer Revenue and Growth Rate (2013-2018) Table South America Bile Duct Cancer Sales by Countries (2013-2018) Table South America Bile Duct Cancer Sales Market Share by Countries (2013-2018) Figure South America Bile Duct Cancer Sales Market Share by Countries in 2017 Table South America Bile Duct Cancer Revenue by Countries (2013-2018) Table South America Bile Duct Cancer Revenue Market Share by Countries (2013-2018) Figure South America Bile Duct Cancer Revenue Market Share by Countries in 2017 Figure Brazil Bile Duct Cancer Sales and Growth Rate (2013-2018) Figure Argentina Bile Duct Cancer Sales and Growth Rate (2013-2018) Figure Colombia Bile Duct Cancer Sales and Growth Rate (2013-2018) Figure Middle East and Africa Bile Duct Cancer Revenue and Growth Rate (2013-2018) Table Middle East and Africa Bile Duct Cancer Sales by Countries (2013-2018) Table Middle East and Africa Bile Duct Cancer Sales Market Share by Countries (2013-2018) Figure Middle East and Africa Bile Duct Cancer Sales Market Share by Countries in 2017 Table Middle East and Africa Bile Duct Cancer Revenue by Countries (2013-2018) Table Middle East and Africa Bile Duct Cancer Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Bile Duct Cancer Revenue Market Share by Countries in 2013 Figure Middle East and Africa Bile Duct Cancer Revenue Market Share by Countries in 2017 Figure Saudi Arabia Bile Duct Cancer Sales and Growth Rate (2013-2018) Figure UAE Bile Duct Cancer Sales and Growth Rate (2013-2018) Figure Egypt Bile Duct Cancer Sales and Growth Rate (2013-2018) Figure Nigeria Bile Duct Cancer Sales and Growth Rate (2013-2018) Figure South Africa Bile Duct Cancer Sales and Growth Rate (2013-2018) Table Global Bile Duct Cancer Sales by Type (2013-2018) Table Global Bile Duct Cancer Sales Share by Type (2013-2018) Table Global Bile Duct Cancer Revenue by Type (2013-2018) Table Global Bile Duct Cancer Revenue Share by Type (2013-2018) Figure Global 5-fluorouracil Sales Growth (2013-2018) Figure Global 5-fluorouracil Price (2013-2018) Figure Global Gemcitabine Sales Growth (2013-2018) Figure Global Gemcitabine Price (2013-2018) Figure Global Cisplatin Sales Growth (2013-2018) Figure Global Cisplatin Price (2013-2018) Figure Global Other Sales Growth (2013-2018) Figure Global Other Price (2013-2018) Table Global Bile Duct Cancer Sales by Application (2013-2018) Table Global Bile Duct Cancer Sales Share by Application (2013-2018) Figure Global Other Sales Growth (2013-2018) Figure Global Bile Duct Cancer Sales, Revenue and Growth Rate (2018-2023) Table Global Bile Duct Cancer Sales Forecast by Regions (2018-2023) Table Global Bile Duct Cancer Market Share Forecast by Regions (2018-2023) Figure North America Sales Bile Duct Cancer Market Forecast (2018-2023) Figure Europe Sales Bile Duct Cancer Market Forecast (2018-2023) Figure Asia-Pacific Sales Bile Duct Cancer Market Forecast (2018-2023) Figure South America Sales Bile Duct Cancer Market Forecast (2018-2023) Figure Middle East and Africa Sales Bile Duct Cancer Market Forecast (2018-2023) Table Global Bile Duct Cancer Sales Forecast by Type (2018-2023) Table Global Bile Duct Cancer Market Share Forecast by Type (2018-2023) Table Global Bile Duct Cancer Sales Forecast by Application (2018-2023) Table Global Bile Duct Cancer Market Share Forecast by Application (2018-2023) Table Distributors/Traders/ Dealers List

Pfizer F. Hoffmann-La Roche Bristol-Myers Squibb Teva Pharmaceutical Eli Lilly and Company Sanofi Fresenius Kabi Mylan